Pérez-Elizondo AD, Ortiz-Ortega L, Contreras-Guzmán C

Language: Spanish
References: 10
Page: 27-29
PDF size: 311.37 Kb.

ABSTRACT

Pityriasis rosea is a common acute, benign and self-limited disseminated rash of unknown origin. It’s characterized by erythematous-squamous plaques with a fine and white scale at the border of the lesion; sometimes produces symptoms. It can be misdiagnosed with other dermatosis receiving wrong treatments.

REFERENCES

1. Chuh A, Lee A, Zawar V, Sciallis G, Kempf W. Pityriasis rosea - an update, Indian J Dermatol Venereol Leprol, 2005; 71: 311-315.

2. Ozge G, Siebel E, Aysen K. Childhood pityriasis rosea, Ped Dermatol, 2009; 26: 750-751.

3. Raspa ML. Pitiriasis rosada. En: Larralde M, Abad ME, Luna P, Dermatología pediátrica, 2a edición, Buenos Aires: Ediciones Journal; 2010: 414-416.

4. Rebora A, Drago F, Broccolo F. Pityriasis rosea and herpesviruses: facts and controversies, Clin Dermatol, 2010; 28: 497-501.

5. López-Carrera I, Durán-McKinster C, Sáez-de-Ocariz MM, Orozco-Covarrubias L, Palacios-López C, Ruiz-Maldonado R. Pitiriasis rosada: un exantema que debe ser reconocido por el médico de primer contacto. Estudio de 30 casos, Acta Pediátr Mex, 2014; 35: 289-294.

6. González LM, Allen R, Janniger CK, Schwartz RA. Pityriasis rosea: An important papuloscamous disorder, Int J Dermatol, 2005; 44: 757-764.

7. Jacyk WK. Pityriasis rosea in Nigerians, Int J Dermatol, 1980; 19: 397-399.

8. Drago F, Vecchio F, Rebora A. Use of high-dose acyclovir in pityriasis rosea, J Am Acad Dermatol, 2006; 54: 82-85.

9. Rassai S, Feily A, Sina N, Abtahian S. Low dose of acyclovir may be an effective treatment against pityriasis rosea: a random investigator-blind clinical trial on 64 patients, J Eur Acad Dermatol Venereol, 2011; 25: 24-26.

10. Sharma PK, Yadav TP, Gautam PK, Taneja N, Satyanarayana L. Erythromycin in pityriasis rosea: a double-blind, placebo controlled clinical trial, J Am Acad Dermatol, 2000; 42: 241-244.